IDEAS home Printed from https://ideas.repec.org/a/aph/ajpbhl/19988871052-1058_6.html
   My bibliography  Save this article

Directly observed therapy and treatment completion for tuberculosis in the United States: Is universal supervised therapy necessary?

Author

Listed:
  • Bayer, R.
  • Stayton, C.
  • Desvarieux, M.
  • Healton, C.
  • Landesman, S.
  • Tsai, W.-Y.

Abstract

Objectives. This study examined the relationship between directly observed therapy and treatment completion rates in the years before and after infusion of federal funding for tuberculosis (TB) control in 1993. Methods. An ecological study of estimated directly observed therapy rates and 12- month treatment completion rates from 1990 through 1994 was undertaken for TB control programs in all 25 cities and counties across the nation with 100 or more incident TB cases in any year from 1990 to 1993. Three cohorts were formed: high treatment completion, intermediate completion, and low completion. Results. In 1990, the median 12-month treatment completion rate was 80% for the entire study population, with a median estimated directly observed therapy rate of 16.8%. By 1994, those rates had increased to 87% and 49.4%, respectively, and increases were shown in all 3 cohorts. Conclusions. Directly observed therapy has had a marked impact on treatment completion rates in jurisdictions with historically low rates. But TB treatment completion rates of more than 90% can be attained with directly observed therapy rates far lower than those proposed by advocates of universal supervised therapy.

Suggested Citation

  • Bayer, R. & Stayton, C. & Desvarieux, M. & Healton, C. & Landesman, S. & Tsai, W.-Y., 1998. "Directly observed therapy and treatment completion for tuberculosis in the United States: Is universal supervised therapy necessary?," American Journal of Public Health, American Public Health Association, vol. 88(7), pages 1052-1058.
  • Handle: RePEc:aph:ajpbhl:1998:88:7:1052-1058_6
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:aph:ajpbhl:1998:88:7:1052-1058_6. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Christopher F Baum (email available below). General contact details of provider: https://www.apha.org .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.